Elixinol Wellness Limited ELLXF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • AU • USD

SharesGrow Score

20/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Elixinol Wellness Limited (ELLXF) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 19/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

20/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

17/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

15/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — ELLXF

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.08

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.02

每股账面价值$0.00

每股营收$0.06

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2017	$-0.02	$0.00	$-2.71M	-
2018	$-0.01	$37.13M	$-860K	-2.3%
2019	$-0.41	$30.71M	$-80.62M	-262.5%
2020	$-0.45	$15.01M	$-104.51M	-696.2%
2021	$-0.04	$9.34M	$-17.03M	-182.3%
2022	$-0.03	$7.06M	$-10.57M	-149.8%
2023	$-0.02	$8.27M	$-7.51M	-90.8%
2024	$-0.01	$14.96M	$-1.72M	-11.5%
2025	$-0.02	$15.49M	$-5.5M	-35.5%